DE2461230A1 - Verfahren zum immunologischen nachweis biologischer teilchen auf einer oberflaeche unter verwendung von radioisotopen, sowie eine vorrichtung zur durchfuehrung des verfahrens - Google Patents
Verfahren zum immunologischen nachweis biologischer teilchen auf einer oberflaeche unter verwendung von radioisotopen, sowie eine vorrichtung zur durchfuehrung des verfahrensInfo
- Publication number
- DE2461230A1 DE2461230A1 DE19742461230 DE2461230A DE2461230A1 DE 2461230 A1 DE2461230 A1 DE 2461230A1 DE 19742461230 DE19742461230 DE 19742461230 DE 2461230 A DE2461230 A DE 2461230A DE 2461230 A1 DE2461230 A1 DE 2461230A1
- Authority
- DE
- Germany
- Prior art keywords
- particles
- substrate
- solution
- biological
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000002245 particle Substances 0.000 title claims description 192
- 238000000034 method Methods 0.000 title claims description 60
- 238000001514 detection method Methods 0.000 title claims description 24
- 230000001900 immune effect Effects 0.000 title claims description 15
- 239000000758 substrate Substances 0.000 claims description 109
- 102000004169 proteins and genes Human genes 0.000 claims description 37
- 108090000623 proteins and genes Proteins 0.000 claims description 37
- 230000005855 radiation Effects 0.000 claims description 37
- 102000036639 antigens Human genes 0.000 claims description 24
- 108091007433 antigens Proteins 0.000 claims description 24
- 239000000427 antigen Substances 0.000 claims description 23
- 229940088597 hormone Drugs 0.000 claims description 16
- 239000005556 hormone Substances 0.000 claims description 16
- 210000002966 serum Anatomy 0.000 claims description 15
- 210000004369 blood Anatomy 0.000 claims description 14
- 239000008280 blood Substances 0.000 claims description 14
- 230000008105 immune reaction Effects 0.000 claims description 12
- 230000002285 radioactive effect Effects 0.000 claims description 11
- 241001465754 Metazoa Species 0.000 claims description 10
- 230000005764 inhibitory process Effects 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 239000012620 biological material Substances 0.000 claims description 2
- 238000011534 incubation Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 238000010998 test method Methods 0.000 claims description 2
- 230000000007 visual effect Effects 0.000 claims description 2
- 238000001179 sorption measurement Methods 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 2
- 239000000969 carrier Substances 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 230000036962 time dependent Effects 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 46
- 239000000243 solution Substances 0.000 description 41
- 208000006454 hepatitis Diseases 0.000 description 11
- 231100000283 hepatitis Toxicity 0.000 description 11
- 230000000694 effects Effects 0.000 description 6
- 208000006379 syphilis Diseases 0.000 description 5
- 238000007654 immersion Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 238000000163 radioactive labelling Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000005250 beta ray Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000009600 syphilis test Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Materials Engineering (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43088474A | 1974-01-04 | 1974-01-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2461230A1 true DE2461230A1 (de) | 1975-07-17 |
Family
ID=23709483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19742461230 Ceased DE2461230A1 (de) | 1974-01-04 | 1974-12-23 | Verfahren zum immunologischen nachweis biologischer teilchen auf einer oberflaeche unter verwendung von radioisotopen, sowie eine vorrichtung zur durchfuehrung des verfahrens |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS50100226A (cg-RX-API-DMAC10.html) |
| CA (1) | CA1039647A (cg-RX-API-DMAC10.html) |
| CH (1) | CH612009A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE2461230A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2257089B1 (cg-RX-API-DMAC10.html) |
| NL (1) | NL181051C (cg-RX-API-DMAC10.html) |
-
1974
- 1974-11-18 CA CA213,939A patent/CA1039647A/en not_active Expired
- 1974-12-20 JP JP14586874A patent/JPS50100226A/ja active Pending
- 1974-12-23 CH CH1719074A patent/CH612009A5/xx not_active IP Right Cessation
- 1974-12-23 DE DE19742461230 patent/DE2461230A1/de not_active Ceased
-
1975
- 1975-01-02 FR FR7500009A patent/FR2257089B1/fr not_active Expired
- 1975-01-03 NL NL7500085A patent/NL181051C/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NL7500085A (nl) | 1975-07-08 |
| FR2257089B1 (cg-RX-API-DMAC10.html) | 1981-05-22 |
| CH612009A5 (en) | 1979-06-29 |
| JPS50100226A (cg-RX-API-DMAC10.html) | 1975-08-08 |
| NL181051C (nl) | 1987-06-01 |
| NL181051B (nl) | 1987-01-02 |
| FR2257089A1 (cg-RX-API-DMAC10.html) | 1975-08-01 |
| CA1039647A (en) | 1978-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2618386C2 (de) | Diagnostisches Verfahren zum Bestimmen der Anwesenheit oder Abwesenheit nachzuweisender biologischer Teilchen | |
| DE2330702C2 (de) | Verfahren zum Bestimmen der Anwesenheit oder Abwesenheit eines spezifischen Proteins in einer biologischen Probe und Vorrichtung zur Durchführung des Verfahrens | |
| DE2512730C2 (de) | Vorrichtung zum Durchführen immunologischer Nachweisreaktionen und Verfahren unter Verwendung einer solchen Vorrichtung | |
| DE2436010C2 (cg-RX-API-DMAC10.html) | ||
| DE3329728C2 (cg-RX-API-DMAC10.html) | ||
| DE68911674T2 (de) | Testverfahren und reagenzsatz dazu. | |
| DE2751588B2 (de) | Verfahren zur Bestimmung eines Liganden oder der Liganden-Bindungskapazität in einem flüssigen Medium | |
| DE2628158A1 (de) | Verfahren, vorrichtung und zusammensetzungen zur analytischen fluoreszenzspektroskopie und immunofluorometrischen untersuchung | |
| DE2633877A1 (de) | Verfahren zur immunpruefung auf antigene in fester phase | |
| DE2804657A1 (de) | Verfahren und vorrichtung zur durchfuehrung von immuntests | |
| DE2419884A1 (de) | Verfahren und vorrichtung zur bestimmung von trijodthyronin | |
| EP1141713A1 (de) | Verfahren und vorrichtung zur bestimmung eines analyten | |
| DE2661010C2 (de) | Immunologisches Reagens und nephelometrisches Untersuchungsverfahren | |
| DE2523207A1 (de) | Verfahren zur bestimmung von antikoerpern | |
| DE2649902C3 (de) | Autoradiografisches Verfahren zur Bestimmung physiologischer Veränderungen in Geweben | |
| DE2727206A1 (de) | Verfahren zur bestimmung des saettigungsgrades des antikoerpers einer biologisch aktiven verbindung in einer biologischen fluessigkeit | |
| DE2820895A1 (de) | Verfahren zur bestimmung einer komponente in einer biologischen fluessigkeit | |
| CH617012A5 (en) | Process for the preparation of substrates with a bimolecular coating and the use thereof. | |
| DE2701928A1 (de) | Radiologisches verfahren zur quantitativen bestimmung von methotrexat | |
| DE2433246C2 (de) | Verfahren zum Bestimmen der Anwesenheit oder Abwesenheit eines spezifischen Proteins in einer biologischen Probe | |
| DE69114247T2 (de) | Analytischer test. | |
| DE3806558A1 (de) | Verfahren zur zellmessung | |
| EP0303284B2 (de) | Immunologisches Bestimmungsverfahren zur Bestimmung von Hapteneigenschaften aufweisenden freien Substanzen | |
| DE2461230A1 (de) | Verfahren zum immunologischen nachweis biologischer teilchen auf einer oberflaeche unter verwendung von radioisotopen, sowie eine vorrichtung zur durchfuehrung des verfahrens | |
| DE2530621A1 (de) | Verfahren zum bestimmen der anwesenheit von antigenen oder ihren antikoerpern in unbekannten proben |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8120 | Willingness to grant licences paragraph 23 | ||
| 8131 | Rejection |